EPIC Study

EPIC Study
Name	EPIC Study
Acronym	EPIC
Type	Prospective cohort study
Start date	1992
End date	2000s
Countries	United Kingdom; European Union member states
Sample size	~500,000
Focus	Diet, lifestyle, cancer risk
Institutions	International Agency for Research on Cancer; Imperial College London; University of Oxford

EPIC Study

The EPIC Study is a large-scale prospective cohort investigation of diet, nutrition, lifestyle, and cancer incidence conducted across multiple European countries. Designed and coordinated through collaborations involving International Agency for Research on Cancer, the study enrolled participants from national cohorts such as the Oxford-based cohorts and centers in France, Germany, Spain, and Italy. Major investigators included teams affiliated with institutions like Imperial College London, Karolinska Institutet, and Inserm, and the study has been cited in relation to findings on dietary factors, cancer subtypes, and chronic disease risk.

Background

The EPIC Study emerged from late 20th-century concerns about rising cancer incidence in Europe and the need to disentangle dietary and lifestyle determinants across diverse populations. Early groundwork drew on precedents set by the Framingham Heart Study and multinational projects like the European Prospective Investigation into Cancer and Nutrition (EPIC) planning groups hosted by International Agency for Research on Cancer. Funders and stakeholders included national research councils and bodies such as Medical Research Council (United Kingdom), Agence nationale de la recherche, and regional health ministries. The study capitalized on existing cohorts from centers including Norway, Sweden, Denmark, and Netherlands to create a harmonized resource for epidemiologic analyses.

Methods

EPIC recruited approximately half a million adults aged predominantly 25–70 years through established cohorts and population-based sampling in centers across United Kingdom, France, Germany, Spain, Italy, Greece, Netherlands, Norway, Sweden, and Denmark. Standardized baseline assessments collected information on diet using validated food frequency questionnaires and 24-hour recalls modeled after instruments applied in Nurses' Health Study and Health Professionals Follow-Up Study, anthropometry following protocols similar to WHO recommendations, and lifestyle factors including tobacco exposure and physical activity grounded in methods used by European Community Respiratory Health Survey. Biological specimens—plasma, serum, DNA, and urine—were banked in centralized and regional biorepositories complying with practices from UK Biobank and Nordic biobanks. Cancer outcomes were ascertained through linkage to national cancer registries like Cancer Research UK databases, hospital records mirroring systems used in Karolinska registers, and mortality follow-up via civil registries such as those maintained in France and Germany. Statistical analyses used Cox proportional hazards models and nested case–control designs comparable to analytic frameworks employed in studies by Harvard School of Public Health and U.S. National Cancer Institute.

Results

EPIC produced numerous high-impact findings linking dietary patterns and specific nutrients to cancer risk and mortality. Key results included associations between processed meat consumption and colorectal cancer risk, echoing evidence from World Health Organization evaluations and influencing classifications by International Agency for Research on Cancer. Analyses implicated high dietary fiber and whole-grain intake in reduced colorectal cancer incidence, consistent with earlier reports from cohorts like Iowa Women's Health Study. EPIC investigations also reported relationships between fruit and vegetable consumption and gastric cancer subtypes, and between body mass index and risks for postmenopausal breast cancer and endometrial cancer, paralleling observations in Women's Health Initiative and Million Women Study data. Biomarker-based nested studies within EPIC identified circulating vitamin D status and hormone profiles as predictors for certain cancers, in line with mechanistic work from National Institutes of Health laboratories and translational research at Karolinska Institutet.

Interpretation

Findings from EPIC have been interpreted as supporting the role of long-term dietary patterns and energy balance in modulating cancer risk across heterogeneous European populations. The consistency of associations for processed meats and adiposity with colorectal and postmenopausal cancers respectively strengthened causal inferences alongside criteria championed in frameworks by Bradford Hill and synthesis efforts such as Cochrane Collaboration reviews. EPIC's integration of biomarker evidence permitted more refined interpretation of exposure–disease pathways, harmonizing observational signals with mechanistic hypotheses generated in settings like European Molecular Biology Laboratory and translational centers in France and Germany.

Limitations

Limitations acknowledged by EPIC investigators include measurement error inherent in dietary self-report instruments despite calibration efforts using 24-hour recalls and biomarkers—challenges similar to those faced by Nurses' Health Study and other large cohorts. Residual confounding by lifestyle factors (e.g., smoking patterns documented in Framingham Heart Study cohorts) and heterogeneity across national centers in food composition databases introduced complexity. The observational design precluded definitive causal attribution without corroboration from randomized trials such as Women's Health Initiative dietary modification components. Loss to follow-up in some regional cohorts and temporal changes in food production and fortification policies within European Union member states also affected generalizability.

Impact and subsequent research

EPIC has substantially influenced dietary guidelines and research agendas across Europe and beyond; its data contributed to risk assessments by International Agency for Research on Cancer and informed policy discussions in bodies like the European Commission and national health agencies. The resource catalyzed nested molecular epidemiology studies integrating genomics and metabolomics with cohorts linked to consortia such as PANCANCER and collaborations with initiatives like UK Biobank for pan-cohort meta-analyses. Subsequent research has leveraged EPIC biospecimens in Mendelian randomization studies drawing on methods popularized by groups at University of Bristol and genomic consortia including GIANT. Ongoing analyses continue to refine understanding of diet–cancer relationships and inform public health recommendations across Europe.

Category:Prospective cohort studies